[Implantable infusion devices. Experience of 360 cases].
Between january 1, 1983 and december 31, 1986, 360 implantable infusion devices were inserted for systemic chemotherapy. Most of the devices were Port A Cath systems. The main complications observed were thrombosis (18 cases, 5%) and infection (8 cases, 2.2%). Since one year the catheters are being introduced by subcutaneous puncture of the subclavian vein, the chambers being placed in a small lateral subclavicular cavity. Intra-operative radiography is necessary to minimize the risk of malposition and thrombosis. These systems, relayed by external pumps, enable chemotherapeutic regimens to be administered sequentially over a 24-hour period.
D006801:Humans; D007260:Infusion Pumps / Q000009:adverse effects; D008722:Methods; D009369:Neoplasms / Q000628:therapy; D011677:Punctures; D013924:Thrombophlebitis / Q000209:etiology
Boîtiers de perfusion implantables. Expérience de 360 cas.